The MMRF Precision Medicine Model
The MMRF actively drives drug discovery and development with a unique model
that has proven results. It is comprised of three interrelated parts.
THE
DATA
BANK
Data generation & integration
THE
LEARNING
NETWORK
Collaboration and discovery
THE
CLINIC
Accelerating trials
MMGI
Gateways
MMRC
CoMMpass
Myeloma Disease Model
- Molecularly targeted therapies
Registry
Translational Network
- Immune therapies
- Novel therapies
The Data Bank
An unprecedented collection
The Learning Network
The Clinic
Collaboration that focuses
A network of best-in-class partners
of high-quality patient
upon access to new targets
launching clinical trials 60% faster
molecular and clinical data.
and drugs to advance
than average.
trials faster than any
other organization.
The Data Bank
of 500 relapsed/refractory patients
progresses over at least 8 years for
In 2005, the MMRF established the first
to obtain “blueprints” of particular
each patient. This will create the largest,
comprehensive tissue banking effort
forms of myeloma and help identify
most comprehensive catalog of multiple
in multiple myeloma. It has accessed
treatment options. In July 2011, the
myeloma genomic and clinical data,
over 4,000 patient samples and clinical
MMRF CoMMpass Study began
and enable physicians to match specific
data from newly diagnosed and
collecting clinical information and
treatment approaches to the patients
relapsed patients.
sequencing myeloma cells from patients’
most likely